Researchers
Bila, Jelena
Date issued
Date issued - custom
Issue Date | Title | Author(s) | Type | М-cat. |
---|---|---|---|---|
2023 | Prevention and management of adverse events during treatment with bispecific antibodies and CAR T cells in multiple myeloma: a consensus report of the European Myeloma Network (✓) | Ludwig, Heinz; ...; Bila, Jelena S. ; ...; (broj koautora 29) | Article | 21aM21a |
2022 | Health-related quality of life in patients with relapsed/refractory multiple myeloma treated with pomalidomide and dexamethasone ± subcutaneous daratumumab: Patient-reported outcomes from the APOLLO trial (✓) | Terpos, Evangelos; ...; Bila, Jelena S. ; ...; (broj koautora 23) | Article | 21aM21a |
2022 | Ocrelizumab associated late-onset neutropenia in the patient with multiple sclerosis - case report and literature review (✓) | Jovićević, Vanja; Bila, Jelena S. ; Mesaroš, Šarlota T. ; Pekmezović, Tatjana D ; Drulović, Jelena S. | Article | 23M23 |
2021 | Bone Marrow Microenvironment Interplay and Current Clinical Practice in Multiple Myeloma: A Review of the Balkan Myeloma Study Group (✓) | Bila, Jelena S. ; Katodritou, Eirini; Guenova, Margarita; Basic-Kinda, Sandra; Coriu, Daniel; Dapcevic, Milena; Ibricevic-Balic, Lejla; Ivanaj, Arben; Karanfilski, Oliver; Zver, Samo;
Beksac, Meral; Terpos, Evangelos; Dimopoulos, Meletios Athanassios;
| Article | 21M21 |
2021 | Daratumumab plus pomalidomide and dexamethasone versus pomalidomide and dexamethasone alone in previously treated multiple myeloma (APOLLO): an open-label, randomised, phase 3 trial (✓) | Dimopoulos, Meletios Athanasios; ...; Bila, Jelena S. ; ...; (broj koautora 23) | Article | 21aM21a |
2021 | Salvage Therapy With Polatuzumab Vedotin, Bendamustine, and Rituximab Prior to Allogeneic Hematopoietic Transplantation in Patients With Aggressive Lymphomas Relapsing After Therapy With Chimeric Antigen Receptor T-Cells-Report on Two Cases (✓) | Gerhardt, Kristin; ...; Sretenović, Aleksandra M.; ...; Todorović, Milena R. ; Bila, Jelena S. ; ...; Vučinić, Vladan | Article | 21M21 |
2020 | A real world multicenter retrospective study on extramedullary disease from Balkan Myeloma Study Group and Barcelona University: analysis of parameters that improve outcome (✓) | Beksac, Meral; Seval, Guldane Cengiz; Kanellias, Nicholas; Coriu, Daniel; Rosinol, Laura; Ozet, Gulsum; Goranova-Marinova, Vesselina; Unal, Ali; Bila, Jelena S. ; Ozsan, Hayri;
Ivanaj, Arben; Ibričević-Balić, Lejla; Kastritis, Efstathios; Blade, Joan; Dimopoulos, Meletios Athanasios;
| Article | 21aM21a |
2020 | Influence of applied CD34+ cell dose on the survival of Hodgkin's lymphoma and multiple myeloma patients following autologous stem cell transplants (✓) | Todorović-Balint, Milena ; Bila, Jelena ; Balint, Bela ; Jeličić, Jelena ; Đunić, Irena ; Antić, Darko ; Kraguljac-Kurtović, Nada ; Vujić, Dragana ; Mihaljević, Biljana | Article | 23M23 |
2020 | Once-per-week selinexor, bortezomib, and dexamethasone versus twice-per-week bortezomib and dexamethasone in patients with multiple myeloma (BOSTON): a randomised, open-label, phase 3 trial (✓) | Grosicki, Sebastian; ...; Bila, Jelena S. ; ...; (broj koautora 58) | Article | 21aM21a |
2019 | Ultrastructural and morphometric analysis of enlarged platelets in congenital isolated asplenia (✓) | Marković, Olivera ; Martinović, Tamara ; Ćirić, Darko ; Trpinac, Dušan ; Čemerikić-Martinović, Vesna; Bumbaširević, Vladimir ; Bila, Jelena ; Marisavljević, Dragomir ; Kravić-Stevović, Tamara | Article | 23M23 |
2018 | Is it possible to improve prognostic value of NCCN-IPI in patients with diffuse large B cell lymphoma? The prognostic significance of comorbidities (✓) | Antic, Darko A ; Jelicic, Jelena J ; Trajkovic, Goran Z; Todorovic-Balint, Milena R; Bila, Jelena S ; Markovic, Olivera B; Petkovic, Ivan Z ; Nikolic, Vesna; Andjelic, Bosko M; Djurasinovic, Vladislava T; | Article | 22M22 |
2018 | 25(OH) vitamin D deficiency in lymphoid malignancies, its prevalence and significance. Are we fully aware of it? (✓) | Đurašinović, Vladislava T.; Mihaljević, Biljana ; Šipetić-Grujičić, Sandra B. ; Ignjatović, Svetlana ; Trajković, Goran ; Todorović-Balint, Milena R. ; Antić, Darko ; Bila, Jelena S. ; Anđelić, Boško M.; Jeličić, Jelena J. ; | Article | 21aM21a |
2017 | Late relapse of Hodgkin's lymphoma - is it different in clinical characteristics and outcome? (✓) | Marković, Olivera B. ; Anđelić, Boško M.; Tarabar, Olivera T. ; Todorović, Milena R. ; Filipović, Branka F. ; Bila, Jelena S. ; Antić, Darko A. ; Marisavljević, Dragomir Ž. ; Stanisavljević, Dejana; Mihaljević, Biljana | Article | 23M23 |
2017 | Autologous stem cell transplants - single center standpoints for lymphoma patients (✓) | Todorović-Balint, Milena ; Bálint, Béla ; Bila, Jelena ; Vujić, Dragana ; Anđelić, Boško; Mihaljević, Biljana | Article | 51M51 |
2017 | The Revised International Staging System Compared to the Classical International Staging System Better Discriminates Risk Groups among Transplant-Ineligible Multiple Myeloma Patients | Bila, Jelena ; Jelicic, Jelena ; Dencic, Fekete Marija; Trajković, Goran ; Sretenovic, Aleksandra; Perunicic, Jovanovic Maja; Antić, Darko ; Mihaljevic, Biljana | Article | 23M23 |
2017 | The role of high-dose therapy and autologous stem cell transplantation in the treatment of patients with multiple myeloma | Bila, Jelena ; Jeličić, Jelena; Todorović Balint, Milena; Antić, Darko ; Vujić, Dragana ; Mihaljević, Biljana | Article | 51M51 |
2016 | The Role of Lymphocyte to Monocyte Ratio, Microvessel Density and HiGH CD44 Tumor Cell Expression in Non Hodgkin Lymphomas | Jelicic, Jelena ; Balint, Milena Todorovic; Jovanovic, Maja Perunicic; Boričić, Novica ; Micev, Marjan ; Stojsic, Jelena; Antić, Darko ; Andjelic, Bosko; Bila, Jelena ; Balint, Bela ; | Article | 22M22 |
2016 | Prognostic Significance of Cereblon Expression in Patients With Multiple Myeloma (✓) | Bila, Jelena ; Sretenovic, Aleksandra; Jelicic, Jelena ; Tošić, Nataša ; Glumac, Irena ; Fekete, Marija Dencic; Antić, Darko ; Todorović, Milena ; Marković, Olivera ; Milojevic, Zoran; | Article | 22M22 |
2016 | Gene Mutation Profiles in Primary Diffuse Large B Cell Lymphoma of Central Nervous System: Next Generation Sequencing Analyses | Todorovic, Balint Milena; Jelicic, Jelena ; Mihaljević, Biljana ; Perić, Jelena ; Stanić, Bojana ; Balint, Bela ; Pejanovic, Nadja; Lucic, Bojana; Tošić, Nataša ; Marjanović, Irena ; | Article | 21M21 |
2016 | OC-07 - Decoding risk for thromboembolic events in lymphoma patients | Antić, Darko ; Milić, Nataša ; Todorović, Milena ; Bila, Jelena ; Anđelić, Boško; Djurasinovic, V.; Sretenovic, A.; Vukovic, V.; Jelicic, J. ; Nikolovski, Srđan ; | Article | 22M22 |